Clinical trial

A Post Authorization Registry Study of Participants Treated With LEQEMBI

NCT07762092

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2026-07-30

PhaseN/A

Study timeline

Study start (actual)2026-07-30Date precision: day

Registry last updated2026-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimers Diseaseunresolved

Interventions

No InterventionOTHER

Sponsors & collaborators

Eisai Limitedlead sponsor

Mapped research locations

TorontoOntario, Canada3 MontrealQuebec, Canada2 VancouverBritish Columbia, Canada1 OttawaOntario, Canada1 EdmontonAlberta, Canada1 LondonOntario, Canada1 CalgaryAlberta, Canada1 QuébecQuebec, Canada1 KingstonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07762092 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.